Insulin Aspart: all 231 studies that test it
Page 1 of 3. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 DiabetesNot yet recruitingNCT07173712Phase 4
- Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDMRecruitingNCT06547619Early Phase 1
- A Trial of Three- and Seven-days Insulin Infusions SetRecruitingNCT06532461Not applicable
- The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesRecruitingNCT06127433Phase 4
- Oxidative Stress in Microvascular Dysfunction Following Gestational DiabetesRecruitingNCT05946785Early Phase 1
- Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With DiabetesRecruitingNCT05641337Phase 3
- Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 DiabetesRecruitingNCT05221359Not applicable
- Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy VolunteersCompletedNCT05539872Phase 2/3Results posted
- Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes MellitusCompletedNCT04460326Phase 3Results posted
- FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic PumpCompletedNCT03977727Phase 3Results posted
- Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 DiabetesCompletedNCT03816761Phase 2Results posted
- Mylan Insulin Aspart StudyCompletedNCT03760068Phase 3Results posted
- Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop TherapyCompletedNCT03554486Phase 4Results posted
- Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic PancreasTerminatedNCT03262116Phase 2/3Results posted
- A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment IntensificationCompletedNCT02906917Phase 3Results posted
- Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 DiabetesCompletedNCT02825251Phase 3Results posted
- Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 DiabetesCompletedNCT02762578Phase 3Results posted
- Additional Insulin for Fat and Protein in Children With Diabetes StudyTerminatedNCT02680054Phase 4Results posted
- Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 DiabetesCompletedNCT02670915Phase 3Results posted
- Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After RamadanCompletedNCT02648217Phase 3Results posted
- Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesCompletedNCT02500706Phase 3Results posted
- Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT02408120Phase 4Results posted
- A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesCompletedNCT02034513Phase 3Results posted
- A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 DiabetesCompletedNCT01999322Phase 3Results posted
- Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes MellitusCompletedNCT01892020Phase 4Results posted
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT01835431Phase 3Results posted
- A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice DailyCompletedNCT01814137Phase 3Results posted
- A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinCompletedNCT01713530Phase 3Results posted
- Point-of-Care Glucose Testing and Insulin SupplementationCompletedNCT01702311Not applicableResults posted
- Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin GlargineCompletedNCT01680341Phase 3Results posted
- Effect of Apidra Compared to Humalog in Decreasing Post-Prandial HyperglycemiaCompletedNCT01621776Not applicableResults posted
- Cardiac Surgery Neuroprotection Study in EldersCompletedNCT01561378Phase 2Results posted
- A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT01513590Phase 3Results posted
- Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTerminatedNCT01486966Phase 4Results posted
- Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyCompletedNCT01474538Phase 3Results posted
- Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminCompletedNCT01388361Phase 3Results posted
- Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing RegimensCompletedNCT01365507Phase 3Results posted
- Carbohydrate Consumption as a Factor in Aspart DosingTerminatedNCT01333514Phase 4Results posted
- Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial LipidsCompletedNCT01293396Phase 4Results posted
- Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT01272193Phase 3Results posted
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes MellitusCompletedNCT01194258Phase 2Results posted
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenCompletedNCT01165684Phase 4Results posted
- Prandial Insulin Dosing in Hospitalized PatientsCompletedNCT01101867Phase 4Results posted
- Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCompletedNCT01068652Phase 4Results posted
- A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01059812Phase 3Results posted
- Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 DiabetesCompletedNCT01045707Phase 3Results posted
- Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesCompletedNCT01045447Phase 3Results posted
- Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01009580Phase 3Results posted
- Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 DiabetesCompletedNCT00978627Phase 3Results posted
- The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal ChildrenCompletedNCT00913497Phase 4Results posted
- Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes MellitusCompletedNCT00842361Phase 2Results posted
- Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00627445Phase 3Results posted
- Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689CompletedNCT00623194Phase 3Results posted
- Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 DiabetesCompletedNCT00613951Phase 2Results posted
- Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes MellitusCompletedNCT00607087Phase 4Results posted
- Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.CompletedNCT00591227Phase 4Results posted
- Memory and Insulin in Early Alzheimer's DiseaseCompletedNCT00581867Phase 1/2Results posted
- Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing TrialCompletedNCT00542620Phase 4Results posted
- Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 DiabetesCompletedNCT00537303Phase 4Results posted
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADsCompletedNCT00537277Phase 4Results posted
- Effect of Insulin Detemir on Use of Energy in Type 1 DiabetesTerminatedNCT00509925Phase 4Results posted
- Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)TerminatedNCT00500240Phase 3Results posted
- Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesCompletedNCT00469092Phase 4Results posted
- Comparison of Insulins Aspart and Lispro in Insulin PumpsCompletedNCT00461331Phase 4Results posted
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 DiabetesCompletedNCT00447382Phase 3Results posted
- Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump TherapyTerminatedNCT00428207Not applicableResults posted
- Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With HyperglycaemiaCompletedNCT00353431Not applicableResults posted
- Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy VolunteersCompletedNCT07560150Phase 2/3
- Role of NADPH Oxidase in Microvascular Dysfunction Following GDMActive, not recruitingNCT05946798Early Phase 1
- A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in ChinaCompletedNCT05802862Phase 3
- AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp StudyCompletedNCT05754424Phase 1
- A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 DiabetesCompletedNCT05199714Not applicable
- AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp StudyCompletedNCT05184868Phase 1
- The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste DysfunctionsStatus unknownNCT05104424Phase 1
- Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DMStatus unknownNCT04965051Not applicable
- Fast Advanced Closed-Loop TherapyCompletedNCT04853030Not applicable
- AT278 and NovoRapid® in Glucose Clamp StudyCompletedNCT04660305Phase 1
- Fast-Acting Insulin Aspart and Insulin Pump SettingsStatus unknownNCT04620967Phase 4
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational DiabetesActive, not recruitingNCT04542148Phase 2
- The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction BolusStatus unknownNCT04414579Phase 4
- Basal Insulin Glycemic ControL With DEglugec vs Aspart Via PumpCompletedNCT04409587Phase 4
- A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy SubjectsCompletedNCT04184466Not applicable
- The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.CompletedNCT04124302Phase 4
- Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus PatientsCompletedNCT04079413Phase 3
- Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealCompletedNCT04019821Phase 4
- Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute HyperkalemiaCompletedNCT04012138Phase 4
- AT247, NovoRapid® and Fiasp® in Glucose Clamp StudyCompletedNCT03959514Phase 1
- Diluted Insulin in Young Children: Bigger Volumes for Smaller PatientsCompletedNCT03666065Early Phase 1
- Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 DiabetesCompletedNCT03659799Phase 4
- Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus PatientsCompletedNCT03436498Phase 1
- A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 DiabetesCompletedNCT03407599Phase 1
- Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)CompletedNCT03328845Phase 4
- A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 DiabetesCompletedNCT03215498Phase 1
- A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes MellitusCompletedNCT02933853Phase 1
- A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese SubjectsCompletedNCT02844790Phase 1
- Evaluation of Glycemic Changes During Exercise in Children With Type 1 DiabetesCompletedNCT02824510Not applicable
- Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.Status unknownNCT02685449Phase 4
- A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic ProfilesCompletedNCT02594033Phase 1
- Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled TrialStatus unknownNCT02590016Phase 4
- Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT02568280Phase 1